EYEwura Seidu Yahaya

Ewura Seidu Yahaya

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ewura Seidu Yahaya has a total of 61 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Medication errors and medication error reporting practices in Ghana: a systematic review

    by Stephen Mensah Arhin, Isaac Tabiri Henneh, Theodora Dedo Azu, Joseph Arhin, Kwasi Sobre Nkrumah, Meshack Antwi-Adjei, Ewura Seidu Yahaya, Phylis Elsie Owusu Agyei, Emmanuel Nkrumah, Frank Osei-Poku, et al.

    Background: Medication errors (MEs) and their underreporting compromise patient safety in Ghana, but the landscape of error types, reporting systems, and barriers has not been comprehensively synthesized. Objective: This systematic review aims to map existing literature on MEs in Ghana and assess the functionality and utilization of reporting systems across healthcare settings. Design: Systematic review conducted in accordance with PRISMA 2020 guidelines. Data sources and methods: PubMed, PubMed Central, Scopus, ScienceDirect, and Google Scholar were searched for studies published between 1 January 2000 and 30 May 2025, with a final update search performed in August 2025 prior to data analysis. Eligible studies were conducted in Ghana and published in English, addressing MEs or medication-error reporting practices across any study design. Study selection, data extraction, and methodological quality appraisal were performed independently by two reviewers, and findings were synthesized narratively due to heterogeneity in study designs and outcome definitions. Results: Reported medication-error prevalence varied widely across included studies (47%–68.4%), reflecting differences in study designs, populations, clinical settings, and definitions of MEs. Omission errors were frequently identified as the most common type, accounting for up to 77.6% of documented errors in some studies. Contributing factors included inadequate training (91.6%), poor supervision (92.3%), and illegible prescriptions (63.7%), with severe underreporting highly evident. Reporting practices were often informal, with many errors conveyed verbally or not documented. Common barriers included fear of blame or disciplinary action, low confidence in reporting systems, insufficient anonymity, lack of standardized forms, limited training, and minimal mentorship. Conclusion: MEs remain a substantial patient-safety concern in Ghana, compounded by informal reporting systems and persistent organizational and cultural barriers. These findings underscore the urgent need to implement structured, non-punitive reporting systems, enhance staff training, and foster a culture of openness to support medication safety.

  • Open Access

    PA-113 Pharmacogenomics of drug-drug interactions in malaria-HIV con-infections: effects on generic artemether-lumefantrine therapy used in Ghana for malaria treatment

    by Nicholas Ekow Thomford, Tracy Kellerman, Oksana Debrah, Akwasi Anyanful, Robert Peter Biney, Dennis Boadi, Ewura Seidu Yahaya, Martins Ekor, George Boateng Kyei

    Background Malaria/HIV co-infection (MHC) is a public health challenge which may present with worse health outcomes due to interactions. Coadministration of artemether lumefantrine (ALU) and antiretroviral therapy may have potential drug-drug interactions that can affect the course of treatment for both diseases. Generic ALU medications are used in Ghana for malaria treatment after RDT or microscopy diagnosis. ALU is metabolized by the enzymes CYP2B6, CYP3A4/5, CYP2A6 and UGTs which can be affected by pharmacogenetics. A better understanding of the effects of MHC on ALU drugs could help prompt treatment, and control of malarial parasites among HIV-infected patients. This study evaluated effects of MHC on ALU drugs used in antimalarial treatment and pharmacogenetic influences on their efficacy. Methods To compare metabolite profiles and treatment outcome in patients on generic ALU for uncomplicated malaria and MHC, this study has recruited about 218 participants. However, we currently have complete preliminary metabolite and genomic data on 52 participants. Blood was taken for microscopy, genotyping using iPLEX Gold microarray and PCR-RFLP, and metabolite analysis using LC-MS/MS. Results Median parasite density was 2119.42/uL, 760.10/uL, 0/uL and 0/uL on days 1,2,3 and 7 for malaria-only participants and 7322.52/uL, 3928.60/uL, 0/uL and 0/uL for MHC participants. Plasma concentrations of dihydroartemisinin (DHA) ranged from 3.30–35.85ng/ml. Desbutyl-lumefantrine (DBL) concentrations ranged from 7.8ng/ml-40.44ng/ml on days 3 and 7. Decreased concentrations of lumefantrine, DBL and DHA were observed across CYP2B6 *1/*1, CYP2B6 *1/*18/*1/*6, CYP3A5 *1/* and CYP3A5 *1/*3/*1/*6/1*/*7 carriers for MHC participants. However, MHC carriers of non-functional haplotypes CYP2B6*6/*6 or *6/*18 or *18/*18 showed increase in lumefantrine, DBL, artemether and DHA concentrations. Conclusion Pharmacogenetic variations affected ALU plasma concentrations although blood parasites were eliminated by day 3 in malaria monoinfected and MHC participants. This however shows there is potential drug-drug interactions between ALU-ART components which can influence the progression of either disease.

  • A feasibility study on the use of a pocket-sized NIR spectrometer and multivariate algorithm to distinguish expired drugs from unexpired ones

    by Jerry Opoku-Ansah, Ewura Seidu Yahaya, Charles Lloyd Yeboah Amuah, Regina Nyorkeh, Agnes Adom-Konadu, Peter Osei-Wusu Adueming, Ernest Teye

    An onsite technique for determining drug integrity in sub-Saharan Africa is needed for ensuring drug integrity and enhancing public health.


  • Open Access

    Isolation and antioxidant activity of 5-methyldihydroflavasperone from ethanol leaf extract of Guiera senegalensis JF Gmel

    by Mosa E.O. Ahmed, Jeremiah Senabe, Ewura S. Yahaya, Gerda Fouche, Paul Steenkamp, Vanessa Steenkamp

    Background: Guiera senegalensis (Ghibaish) is a medicinal plant extensively used in central and west Africa for the management of various diseases. Aim: This study aimed to determine the antioxidant activity of the ethanol leaf extract of the plant. Method: The ethanol leaf extract was sequentially sub-fractionated using liquid–liquid extraction, vacuum-liquid chromatography and preparative thin layer chromatography. Ultra-performance liquid chromatography with accurate mass spectrometry and nuclear magnetic resonance were employed to isolate and confirm the identity of the most abundant compound. The antioxidant activity of the fractions and isolated compound was assessed by bioautography analysis and the 2,2-diphenyl-1-picrylhydrazyl hydrate (DPPH) radical scavenging assay. Results: The dichloromethane subfraction contained the most promising antioxidant activity (IC50 = 3.18 µg/mL). Purification of this subfraction led to the isolation of a brown crystalline compound, which was identified as 5-methyldihydroflavasperone (IC50 > 4000 µg/mL). Conclusion: This is the first report of the isolation of 5-methyldihydroflavasperone from the ethanol leaf extracts of G. senegalensis. This compound was not found to be responsible for the antioxidant activity observed. Further research is warranted to identify the compound responsible for the antioxidant activity.


  • Turning Up the Volume for Precision Herbal Medicine in Africa in an Era of COVID-19 and Planetary Biodiversity Loss

    by Nicholas Ekow Thomford, Ewura Seidu Yahaya, Martins Ekor, Charles Awortwe

    What would it take in terms of the structural reforms in science, technology, and culture to cultivate sustainable therapeutic and preventive medicine innovations against zoonotic infections such as coronavirus disease 2019 (COVID-19) in the 21st century? In May 2019, the Intergovernmental Science-Policy Platform on Biodiversity and Ecosystem Services warned that “around one million animal and plant species are now threatened with extinction.” Biodiversity is essential for drug discovery and development. We are currently facing a dual challenge in therapeutics innovation with COVID-19 and loss in planetary biodiversity. Hence, there is an urgent need for new ideas and strategies for drug discovery as well as repurposed drugs for the COVID-19 pandemic. To these ends, the existing scholarship in, and the field of precision herbal medicine provide an alternative source for discovery of novel therapeutics against the novel coronavirus. We propose that the application of precision herbal medicine in Africa could usefully contribute to current efforts for therapeutics innovation for the COVID-19 pandemic, and beyond. The pandemic calls for interdisciplinary dialogue and turning up the volume for precision herbal medicine in Africa, and importantly, in ways informed by robust systems science as well as broad public engagement to codesign medicines in the 21st century.


  • Leaf and root bark extracts of Ziziphus abyssinica Hochst ex. A. Rich (Rhamnaceae) ameliorate hepatic, renal and splenic injuries induced by phenylhydrazine in rats

    by Isaac T. Henneh, Phyllis E. Owusu Agyei, Ernest Obese, Robert P. Biney, Meshack Antwi-Adjei, Ewura S. Yahaya, Ernest Asiamah, Joseph Acquah-Mills, Douglas O. Boateng, Martins Ekor

    Objectives: Ziziphus abyssinica (ZA) is employed in managing several ailments in Traditional African Medicine. Scientific evaluations are necessary to ascertain the medicinal potential of ZA as a source of new drug molecules. This study investigated the possible therapeutic benefit of ZA leaf (ZAL) and root bark (ZARB) extracts in an experimental model of multi-organ injuries induced by phenylhydrazine (PHZ). Methods: Hyperbilirubinaemia, hepatotoxicity, nephrotoxicity and splenic injuries were induced by pretreating albino rats with PHZ (40 mg/kg, p.o. ) for two alternate days. Afterward, six out of the eight groups of rats (n = 5) used were treated with either ZAL or ZARB (30, 100 and 300 mg/kg/day, p.o .) for seven days. Naïve control rats received saline without PHZ whereas negative control group received saline after PHZ. After one week of treatment, rats were sacrificed and blood collected for assessment of haematological and biochemical parameters. Liver, kidney and spleen sections were processed for histology and examined under light microscope. Results: Data indicate that PHZ significantly (p < 0.05) increased total bilirubin, serum alanine aminotransferase, aspartate aminotransferase, blood urea nitrogen (BUN), creatinine and BUN/creatinine ratio whereas red blood cell count was significantly reduced. These anomalies were significantly reversed in rats treated with ZAL or ZARB. The therapeutic effect of the extracts was supported by photomicrographs of the liver, kidney, and spleen of rats which revealed recovery from PHZ-mediated pyknosis, glomerular degeneration and multiple splenic necrosis respectively. Conclusions: Overall, data from this study suggest that ZA may be useful in multiple organ injuries associated with PHZ-like xenobiotic toxicity.


  • Open Access

    Protective effect of Erythrina senegalensis sequential extracts against oxidative stress in SC-1 fibroblasts and THP-1 macrophages

    by Ewura S. Yahaya, Werner Cordier, Paul A. Steenkamp, Vanessa Steenkamp

    Protective effect of Erythrina senegalensis sequential extracts against oxidative stress in SC-1 fibroblasts and THP-1 macrophages


  • Attenuation of oxidative stress and artificial wound closure in C2C12 myoblasts induced by sequential extracts of Boerhavia diffusa

    by Ewura Seidu Yahaya, Werner Cordier, Paul Anton Steenkamp, Vanessa Steenkamp

    Objectives: Whole plants of Boerhavia diffusa L. are widely used medicine in Ghana and other tropical countries, for the treatment of wounds and other ailments. The aim of the study was to determine the ability of sequential extracts of B. diffusa to influence oxidation and wound closure in myoblast cells in vitro. Methods: Sequential extracts were prepared from the whole plant using four solvents of increasing polarity (hexane, ethyl acetate, methanol and water). Cytotoxicity was determined using the sulforhodamine B staining assay, phase-contrast microscopy, plasDIC microscopy and live–dead staining. Extracts were tested for their ability to reduce 2,2′-azobis(2-amidinopropane) dihydrochloride (AAPH)-induced oxidation and mediate cell migration after artificial wound generation in C2C12 myoblast cells using the scratch wound assay. Key findings: All extracts indicated negligible cytotoxicity (IC50 > 100 μg/ml), and microscopic evaluation showed no difference from negative controls. AAPH induced a 2.87-fold increase in reactive oxygen species compared to the negative control. Pretreatment with 100 μg/ml of the extracts reduced AAPH-induced oxidation to 1.70-fold of the untreated controls (P < 0.001). Wound closures in the methanol and water extract treatments were 18.08% and 20.76% higher than the negative control, respectively (P < 0.01). Conclusions: These findings indicate that the hexane, methanol and water extracts of B. diffusa whole plant promote artificial wound healing and protection against oxidation in vitro and therefore warrant further research into its mechanisms of wound healing.


  • Ethnomedicinal extracts of three Ghanaian plants attenuate oxidation in SC-1 fibroblasts, while perturbing cellular migration

    by Ewura S Yahaya, Werner Cordier, Paul A Steenkamp, Vanessa Steenkamp

    Background: Ethnomedicinal preparations have for many years served as medication for treatment of diverse diseases. These possess various pharmacologically-active phytochemicals which may be harnessed for the treatment of diseases such as wounds. This study investigated the ability of ethnomedicinal extracts prepared from Aspilia africana CD Adams, Boerhavia diffusa L. and Erythrina senegalensis DC. to alter reactive oxygen species (ROS) release and cellular migration in SC-1 fibroblasts as surrogate markers for wound healing. Methods: Extracts were screened for major phytochemical classes using thin-layer chromatography and ultra-performance liquid chromatography coupled to time of flight mass spectrometry (UPLC-TOF-MS). Cytotoxicity in SC-1 fibroblasts was assessed using sulforhodamine B staining, and morphological examination via microscopy. The effect on AAPH-induced ROS release was measured using dichlorofluorescein diacetate activation. The effect on cellular migration was determined microscopically using the scratch wound method. Results: Phytochemical classes such as alkaloids, flavonoids and phenols were identified in all three extracts. Chromatograms created using UPLC-TOF-MS showed the absence of ascorbic acid, and kaempferol, whilst traces of neobavaisoflavone was detected in E. senegalensis. None of the extracts was cytotoxic. E. senegalensis reduced intracellular ROS and cellular migration by 35% and 65% at 100 µg/mL, respectively. Conclusion: Although E. senegalensis reduced oxidative stress, cellular migration was hindered. Free radicals are associated with activation of proliferative and migratory pathways, and thus may be implicated in the reduced migration observed. The latter may result in reduced wound healing. Further investigation is necessary to identify bioactive components, and elucidate the mechanistic pathways involved.